What the Published Data Shows Across the research literature, B12 deficiency rates after bariatric surgery fall in the following ranges (3): Roux-en-Y gastric bypass: approximately 2% to 80%, depending on follow-up duration and supplementation Sleeve gastrectomy: 0% to 36.4%, with deficiency often emerging up to two years post-surgery Biliopancreatic diversion with duodenal switch: highest rates, often requiring lifelong parenteral supplementation Weight loss medications: up to 2.6% incidence within one year of treatment These are wide ranges because research has pooled studies with very different follow-up windows and supplementation regimens
Although they are marketed as next-generation biohacks and research chemicals, many peptides are not approved for human use and lack basic clinical testing
The potential therapeutic uses of BPC-157 are still under investigation with many preliminary and animal studies showing promising potential in supporting healing, recovery, and having a beneficial impact on the bodys inflammatory response
For further guidance on aseptic preparation and beyond-use dating of injectable products in UK practice, refer to SPS (Specialist Pharmacy Service) resources and MHRA guidance on the manufacture of IMPs
Always request a Certificate of Analysis (CoA) from your supplier before use in any research protocol